Point72 Asia (Singapore) Pte. Ltd. Pds Biotechnology Corp Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $532 Billion
- Q3 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 22,426 shares of PDSB stock, worth $35,881. This represents 0.02% of its overall portfolio holdings.
Number of Shares
22,426
Previous 39,349
43.01%
Holding current value
$35,881
Previous $115 Million
25.7%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding PDSB
# of Institutions
64Shares Held
4.05MCall Options Held
253KPut Options Held
70.4K-
Vanguard Group Inc Valley Forge, PA1.52MShares$2.43 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$779,1470.0% of portfolio
-
Geode Capital Management, LLC Boston, MA415KShares$664,1800.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny234KShares$374,7340.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA134KShares$214,8160.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $45.5M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...